SEC Comment Letter for IMMUTEP Ltd (IMMP, PRRUF) (CIK 0001506184) (IMMP) — Oct 22, 2019
IMMUTEP Ltd (IMMP, PRRUF) (CIK 0001506184)
Date: Oct. 22, 2019 · CIK: 0001506184 · Accession: 0000000000-19-014758
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-234208
Letter
October 22, 2019 Marc Voigt Chief Executive Officer Immutep Limited Level 12, 95 Pitt Street Sydney, NSW 2000 Australia Re:Immutep Limited Registration Statement on Form F-3 Filed October 15, 2019 File No. 333-234208 Dear Mr. Voigt: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Irene Paik at 202-551-6553 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Andrew S. Reilly - Baker & McKenzie
Show Raw Text
October 22, 2019
Marc Voigt
Chief Executive Officer
Immutep Limited
Level 12, 95 Pitt Street
Sydney, NSW 2000
Australia
Re:Immutep Limited
Registration Statement on Form F-3
Filed October 15, 2019
File No. 333-234208
Dear Mr. Voigt:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Irene Paik at 202-551-6553 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Andrew S. Reilly - Baker & McKenzie